miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review
- PMID: 38679648
- DOI: 10.1186/s43046-024-00220-8
miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review
Abstract
Background: MicroRNAs (miRNAs or miRs) are highly conserved non-coding RNAs with a short length (18-24 nucleotides) that directly bind to a complementary sequence within 3'-untranslated regions of their target mRNAs and regulate gene expression, post-transcriptionally. They play crucial roles in diverse biological processes, including cell proliferation, apoptosis, and differentiation. In the context of cancer, miRNAs are key regulators of growth, angiogenesis, metastasis, and drug resistance.
Main body: This review primarily focuses on miR-939 and its expanding roles and target genes in cancer pathogenesis. It compiles findings from various investigations. MiRNAs, due to their dysregulated expression in tumor environments, hold potential as cancer biomarkers. Several studies have highlighted the dysregulation of miR-939 expression in human cancers.
Conclusion: Our study highlights the potential of miR-939 as a valuable target in cancer diagnosis, prognosis, and treatment. The aberrant expression of miR-939, along with other miRNAs, underscores their significance in advancing our understanding of cancer biology and their promise in personalized cancer care.
Keywords: Cancer; Diagnostic; Prognostic; Therapeutic; miR-939.
© 2024. The Author(s).
Similar articles
-
miR-638: A Promising Cancer Biomarker with Therapeutic Potential.Curr Mol Med. 2023;23(5):377-389. doi: 10.2174/1566524022666220405125900. Curr Mol Med. 2023. PMID: 35382724 Review.
-
Functional Role of microRNA-23b-3p in Cancer Biology.Microrna. 2018;7(3):156-166. doi: 10.2174/2211536607666180629155025. Microrna. 2018. PMID: 29962353 Review.
-
Therapeutic targeting of miRNA-216b in cancer.Cancer Lett. 2020 Aug 1;484:16-28. doi: 10.1016/j.canlet.2020.04.020. Epub 2020 May 5. Cancer Lett. 2020. PMID: 32387443 Review.
-
The diagnostic, prognostic role and molecular mechanism of miR-328 in human cancer.Biomed Pharmacother. 2023 Jan;157:114031. doi: 10.1016/j.biopha.2022.114031. Epub 2022 Nov 19. Biomed Pharmacother. 2023. PMID: 36413837 Review.
-
Dysregulation of miR-638 in the progression of cancers.Pathol Res Pract. 2021 Apr;220:153351. doi: 10.1016/j.prp.2021.153351. Epub 2021 Jan 29. Pathol Res Pract. 2021. PMID: 33642053
Cited by
-
Systemic strategies for osteosarcoma: advances and future directions.Discov Oncol. 2025 Jul 18;16(1):1367. doi: 10.1007/s12672-025-02208-9. Discov Oncol. 2025. PMID: 40679695 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical